Healthcare Realty Trust Inc
NYSE:HR

Watchlist Manager
Healthcare Realty Trust Inc Logo
Healthcare Realty Trust Inc
NYSE:HR
Watchlist
Price: 17.445 USD 0.49% Market Closed
Market Cap: $6.1B

Healthcare Realty Trust Inc
Investor Relations

Healthcare Realty Trust Inc. is a real estate investment trust (REIT) that specializes in owning, managing, and developing properties primarily associated with outpatient healthcare services. Picture this company as a crucial puzzle piece in the ever-evolving healthcare landscape; it provides the physical space where crucial medical services are delivered, from comprehensive outpatient clinics to specialized centers for diagnostics and treatment. Born from a recognition of the rising demand for healthcare facilities, the company has meticulously assembled a portfolio that supports the healthcare sector's shifting focus toward outpatient care, where patients can receive specialized services without the need for an overnight hospital stay.

In terms of its business model, Healthcare Realty Trust earns revenue primarily through leasing its properties to a variety of healthcare providers, from major hospital systems to smaller independent medical practices. By working closely with these tenants, the company ensures that facilities are tailored to meet healthcare providers' specific needs. This tenant-focused strategy not only helps the company maintain high occupancy rates but also encourages long-term leasing agreements. Consequently, Healthcare Realty Trust's steady stream of rental income becomes a reliable source of cash flow, which is further supported by its adept property management and strategic acquisitions, reinforcing its reputation as a leading provider of healthcare real estate solutions.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Oct 31, 2025
AI Summary
Q3 2025

FFO & Guidance: Normalized FFO per share rose 5% year-over-year to $0.41, beating expectations, and 2025 FFO guidance was raised by $0.01 to a new range of $1.59–$1.61.

Strong Operations: Same-store cash NOI grew 5.4%, occupancy improved to 91.1%, and tenant retention reached nearly 89%—the highest level in six years.

Portfolio Transformation: $500 million of assets sold at a 6.5% blended cap rate year-to-date; another $700 million is under contract or LOI, bringing leverage down to 5.8x net debt to EBITDA.

Capital Allocation: The board authorized a new $1 billion ATM equity program and up to $500 million in share buybacks, but management emphasized no immediate plans to issue equity.

Growth Initiatives: Redevelopment and development projects are expected to contribute approximately $16 million in stabilized NOI, and capital is being redeployed to higher-yielding internal investments.

Market Conditions: Outpatient medical sector demand continues to outpace supply, driving occupancy near record highs and improving lease economics.

Key Financials
Normalized FFO per Share
$0.41
Same-Store Cash NOI Growth
5.4%
FAD per Share
$0.33
Quarterly Payout Ratio
73%
Same-Store Occupancy
91.1%
Tenant Retention
89%
Annual Lease Escalators
3.1%
Leasing Pipeline
1.1 million sq ft
Assets Sold YTD
$500 million
Blended Cap Rate on Dispositions (YTD)
6.5%
Disposition Pipeline Remaining
$700 million
Net Debt to Adjusted EBITDA
5.8x
Normalized G&A (Q3)
$9.7 million
Redevelopment Budget Added (Q3)
$60 million
Expected Incremental NOI from Redevelopment (5 Projects)
$8 million
Expected Stabilized NOI from 2 Development Projects
$8 million
Annual Carry Cost on Land Parcels
$1.5 million
Earnings Call Recording
Other Earnings Calls

Management

Ms. Constance B. Moore
Interim President, CEO & Director
No Bio Available
Mr. Robert E. Hull
Executive VP & COO
No Bio Available
Ms. Julie F. Wilson
Executive VP & Chief Administrative Officer
No Bio Available
Mr. John M. Bryant Jr.
Executive VP & General Counsel
No Bio Available
Mr. Austen Helfrich
Interim Chief Financial Officer
No Bio Available
Ms. Amanda L. Callaway
Senior VP & Chief Accounting Officer
No Bio Available
Mr. Andy Baxter
VP & CTO
No Bio Available
Mr. Ronald M. Hubbard
Vice President of Investor Relations
No Bio Available
Ms. Bethany A. Mancini
Associate Vice President of Corporate Communications
No Bio Available
Ms. Revell M. Michael
Vice President of Marketing
No Bio Available

Contacts

Address
TENNESSEE
Nashville
3310 W End Ave
Contacts